Basic info
Industry
biotechnology research
Sectors
Biotechnology
Pharmaceutical
Business Development
Sales and Marketing
Immuno-Oncology
Biotech
Clinical Research
Health Care
Oncology
Pharmaceuticals
Leadership
Global
Research and Development
Immunology
Date founded
2014
Funding rounds raised
Total raised
$73M
from 13 investors over 13 rounds
I
ImmunOs Therapeutics AG raised $73M on June 7, 2022
Investors: Gimv, GL Capital Group, PEAK6, Samsara BioCapital, Mission BioCapital, Redalpine and Lightspeed Venture Partners
I
ImmunOs Therapeutics AG raised undisclosed on April 12, 2021
Investors: European Union and Innosuisse - Schweizerische Agentur für Innovationsförderung
I
ImmunOs Therapeutics AG raised $15M on December 10, 2019
Investors: Redalpine, BioMedPartners and Wille Finance
I
ImmunOs Therapeutics AG raised undisclosed on October 1, 2018
Investors: University of Zurich (UZH) Tierspital